Unlike an flexible savings account, health savings account funds don't expire at the end of the year and they're portable. » Read More
Hillary Clinton faced flak after reportedly wearing an Armani jacket worth more than $12,000 during a speech about inequality.
Pharma bad boy Martin Shkreli unloaded as he left the federal courthouse in Brooklyn Monday.
The ex-Turing Pharmaceuticals CEO is charged with looting a pharma company he founded to pay off investors he was suspected of scamming.
Valeant Pharmaceuticals reported a lower-than-expected quarterly profit and cut its full-year earnings and revenue forecast.
As the world's largest cancer research conference gets underway, here's how to play the stocks.
Alzheimer's patients might be showing early warning signs that are missed by tests. Some researchers say they know one way to change that.
Spending on cancer medicines totaled $107 billion in 2015 and will exceed $150 billion by 2020, the IMS Institute for Healthcare Informatics says.
Insurance plans sold on Obamacare marketplaces were projected to see lower price hikes than plans sold outside.
Forbes reduced its estimate of the net worth of Elizabeth Holmes, the founder and CEO of Theranos, to zero from $4.5 billion last year.
Former Wells Fargo CEO Dick Kovacevich says Theranos is experiencing "normal things" common to start-ups.
Johnson & Johnson said it would acquire Vogue International for $3.3 billion, adding brands such as OGX shampoos and FX hair styling products.
Nearly half of all poor Texans still lack health insurance despite coverage gains in other segments of the population since the fall of 2013.
A group of scientists found that suppressing activity in key places appeared to lessen addictive and reward-seeking behavior.
The injection of stem cells into the brains of chronic stroke patients has led to promising results, Stanford University says.
From how to enroll to which options to choose, what you don’t know about Medicare could cost you.
Biotech startup NantHealth launched into the market Thursday after its initial public offering, with the stock surging nearly 33 percent.
Get the best of CNBC in your inbox